Jane Ives

808 total citations
12 papers, 619 citations indexed

About

Jane Ives is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Jane Ives has authored 12 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Jane Ives's work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Viral-associated cancers and disorders (3 papers). Jane Ives is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Viral-associated cancers and disorders (3 papers). Jane Ives collaborates with scholars based in United Kingdom, Canada and United States. Jane Ives's co-authors include Guy Boivin, Nathalie Goyette, Mahdi Farhan, Alan G. Jardine, Atul Humar, Ajit P. Limaye, Emily A. Blumberg, Daniel Abramowicz, Ingeborg A. Hauser and Flavio Vincenti and has published in prestigious journals such as Journal of Medicinal Chemistry, Transplantation and The Pediatric Infectious Disease Journal.

In The Last Decade

Jane Ives

12 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Ives United Kingdom	11	416	138	112	110	99	12	619
Tammy Ojo United States	8	282 0.7×	85 0.6×	145 1.3×	64 0.6×	16 0.2×	11	507
Florence Aulagnon France	7	89 0.2×	204 1.5×	125 1.1×	33 0.3×	24 0.2×	9	375
Gabriel Bernal Spain	9	154 0.4×	174 1.3×	68 0.6×	39 0.4×	11 0.1×	17	351
H Kreis France	10	94 0.2×	101 0.7×	90 0.8×	75 0.7×	35 0.4×	33	459
Diane R. Post United States	4	219 0.5×	347 2.5×	257 2.3×	90 0.8×	40 0.4×	5	539
Mohamed Elrefaei United States	13	130 0.3×	27 0.2×	33 0.3×	39 0.4×	28 0.3×	38	467
Caroline Wehmeier Switzerland	13	107 0.3×	349 2.5×	175 1.6×	110 1.0×	13 0.1×	31	455
M. Harler United States	5	171 0.4×	454 3.3×	253 2.3×	74 0.7×	14 0.1×	13	610
Catherine S. Forconi United States	9	109 0.3×	26 0.2×	16 0.1×	93 0.8×	36 0.4×	20	269
Laura Cardeñoso Spain	12	256 0.6×	12 0.1×	13 0.1×	89 0.8×	24 0.2×	26	415

Countries citing papers authored by Jane Ives

Since Specialization

Citations

This map shows the geographic impact of Jane Ives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Ives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Ives more than expected).

Fields of papers citing papers by Jane Ives

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Ives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Ives. The network helps show where Jane Ives may publish in the future.

Co-authorship network of co-authors of Jane Ives

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Ives. A scholar is included among the top collaborators of Jane Ives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Ives. Jane Ives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Jaffe, Glenn J., et al.. (2022). Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab. Ophthalmology Retina. 6(9). 786–795. 2 indexed citations

Muntoni, Francesco, Enrico Bertini, Giacomo P. Comi, et al.. (2020). Long-term follow-up of patients with type 2 and non-ambulant type 3 spinal muscular atrophy (SMA) treated with olesoxime in the OLEOS trial. Neuromuscular Disorders. 30(12). 959–969. 18 indexed citations

Bradley, Denise, et al.. (2016). Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients 4 Months of Age and Younger. The Pediatric Infectious Disease Journal. 35(12). 1324–1328. 12 indexed citations

Boivin, Guy, Nathalie Goyette, Mahdi Farhan, Jane Ives, & Robert C. Elston. (2012). Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis. Journal of Clinical Virology. 53(3). 208–213. 45 indexed citations

Goyette, Nathalie, et al.. (2010). Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis. Journal of Clinical Virology. 47(4). 321–324. 30 indexed citations

Chou, Sunwen, Gail I. Marousek, Guy Boivin, et al.. (2010). Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis. Transplantation. 90(12). 1409–1413. 23 indexed citations

Humar, Atul, Ajit P. Limaye, Emily A. Blumberg, et al.. (2010). Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study. Transplantation. 90(12). 1427–1431. 149 indexed citations

Nashan, Björn, Faouzi Saliba, François Durand, et al.. (2009). Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transplantation. 15(2). 136–147. 32 indexed citations

Boivin, Guy, Nathalie Goyette, Halvor Rollag, et al.. (2009). Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antiviral Therapy. 14(5). 697–704. 82 indexed citations

10.

McNeil, Keith, Allan R. Glanville, Thorsten Wahlers, et al.. (2006). Comparison of Mycophenolate Mofetil and Azathioprine for Prevention of Bronchiolitis Obliterans Syndrome in De Novo Lung Transplant Recipients. Transplantation. 81(7). 998–1003. 88 indexed citations

11.

PARKES, K. E. B., Philipp Ermert, Jane Ives, et al.. (2003). Use of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease Inhibitors. Journal of Medicinal Chemistry. 46(7). 1153–1164. 125 indexed citations

12.

Herbert, Jeff, Winston L. Hutchinson, Jane Ives, et al.. (2002). Influenza Virus Infection is not Affected by Serum Amyloid P Component. Molecular Medicine. 8(1). 9–15. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact